Gamma interferon supplementation for melioidosis.
Koh
Gavin C K W
GC
Limmathurotsakul
Direk
D
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D016957:Burkholderia pseudomallei / Q000187:drug effects / Q000276:immunology; D002442:Ceftazidime / Q000494:pharmacology / Q000627:therapeutic use; D002455:Cell Division / Q000187:drug effects; D004195:Disease Models, Animal; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005260:Female; D007371:Interferon-gamma / Q000494:pharmacology / Q000627:therapeutic use*; D008264:Macrophages / Q000276:immunology / Q000382:microbiology; D008554:Melioidosis / Q000188:drug therapy*; D051379:Mice; D008807:Mice, Inbred BALB C
D000900:Anti-Bacterial Agents; D007371:Interferon-gamma; D002442:Ceftazidime